2051.9000 61.00 (3.06%)
NSE Sep 05, 2025 15:31 PM
Volume: 977.4K
 

2051.90
3.06%
Deven Choksey
We have revised our FY26E/FY27E EPS estimates by -1.1 %/+13.2%, respectively, as we factor in improvement in EBITDA margins on account of improving mix and launch of high margin products.
Glenmark Pharmaceuticals Ltd.'s price crossed above 50Day SMA today
More from Glenmark Pharmaceuticals Ltd.
Recommended